Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of cholestagel to reduce the frequency of
soft and liquid stools per day in patients with CD in clinical remission with symptoms of BAM
and to assess the improvement in stool consistency and quality of life in these patients and
to assess the safety of cholestagel.